Akari Therapeutics PLC (AKTX) stock is up more than 34% Tuesday and has risen 129.59% over the last 12 months. The average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives AKTX stock a score of 89 out of a possible 100.
That score is primarily influenced by a long-term technical score of 99. AKTX’s score also includes a short-term technical score of 92. The fundamental score for AKTX is 77. In addition to the average rating from Wall Street analysts, AKTX stock has a mean target price of $7.00. This means analysts expect the stock to increase 55.56% over the next 12 months.
What’s Happening with AKTX Stock Today
Akari Therapeutics PLC (AKTX) stock has risen 34.33% while the S&P 500 has risen 0.25% as of 10:06 AM on Tuesday, Apr 23. AKTX has risen $1.15 from the previous closing price of $3.35 on volume of 8,545,689 shares. Over the past year the S&P 500 is up 9.17% while AKTX has risen 129.59%. AKTX lost -$2.84 per share in the over the last 12 months.